Viscoelastic Haemostatic Assays in Cardiovascular Critical Care

The initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aniket S Rali, Ahmed M Salem, Melat Gebre, Taylor M Garies, Siva Taduru, Arthur W Bracey
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/c564d77b82794e2784fb8683204eb9c6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c564d77b82794e2784fb8683204eb9c6
record_format	dspace
spelling	oai:doaj.org-article:c564d77b82794e2784fb8683204eb9c62021-12-04T16:03:55ZViscoelastic Haemostatic Assays in Cardiovascular Critical Care10.15420/cfr.2020.222057-75592057-7540https://doaj.org/article/c564d77b82794e2784fb8683204eb9c62021-02-01T00:00:00Zhttps://www.cfrjournal.com/articles/viscoelastic-haemostatic-assays-cardiovascular-critical-carehttps://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559The initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis and thromboembolic events with the use of mechanical circulatory support and ventricular assist devices. The frequent use of antiplatelet and anticoagulation therapy, in addition to the presence of concomitant conditions that may lead to a propensity to bleed, such as renal and liver dysfunction, present unique challenges. The use of viscoelastic haemostatic assays provides an additional tool allowing clinicians to strike a delicate balance of attaining adequate anticoagulation while minimising the risk of bleeding complications. In this review, the authors discuss the role that viscoelastic haemostatic assay plays in cardiac populations (including cardiac surgery, heart transplantation, extracorporeal membrane oxygenation, acute coronary syndrome and left ventricular assist devices), and identify areas in need of further study.Aniket S RaliAhmed M SalemMelat GebreTaylor M GariesSiva TaduruArthur W BraceyRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 7, Iss , Pp - (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
description	The initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis and thromboembolic events with the use of mechanical circulatory support and ventricular assist devices. The frequent use of antiplatelet and anticoagulation therapy, in addition to the presence of concomitant conditions that may lead to a propensity to bleed, such as renal and liver dysfunction, present unique challenges. The use of viscoelastic haemostatic assays provides an additional tool allowing clinicians to strike a delicate balance of attaining adequate anticoagulation while minimising the risk of bleeding complications. In this review, the authors discuss the role that viscoelastic haemostatic assay plays in cardiac populations (including cardiac surgery, heart transplantation, extracorporeal membrane oxygenation, acute coronary syndrome and left ventricular assist devices), and identify areas in need of further study.
format	article
author	Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey
author_facet	Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey
author_sort	Aniket S Rali
title	Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
title_short	Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
title_full	Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
title_fullStr	Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
title_full_unstemmed	Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
title_sort	viscoelastic haemostatic assays in cardiovascular critical care
publisher	Radcliffe Medical Media
publishDate	2021
url	https://doaj.org/article/c564d77b82794e2784fb8683204eb9c6
work_keys_str_mv	AT aniketsrali viscoelastichaemostaticassaysincardiovascularcriticalcare AT ahmedmsalem viscoelastichaemostaticassaysincardiovascularcriticalcare AT melatgebre viscoelastichaemostaticassaysincardiovascularcriticalcare AT taylormgaries viscoelastichaemostaticassaysincardiovascularcriticalcare AT sivataduru viscoelastichaemostaticassaysincardiovascularcriticalcare AT arthurwbracey viscoelastichaemostaticassaysincardiovascularcriticalcare
_version_	1718372758739484672

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care

Ejemplares similares